menu
    • menu

    Company profile for Laboratorios HIPRA

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Laboratorios HIPRA SA manufactures and distributes biological and pharmacological veterinary products. The Company markets its products to agricultural operations and livestock breeders. Laboratorios HIPRA serves customers in Spain. We are an Animal Health company and this is our sole activity.Through our own commercial subsidiaries and a global distribution network, we reach customers from more than 100 countries. HIPRA aro...
    Laboratorios HIPRA SA manufactures and distributes biological and pharmacological veterinary products. The Company markets its products to agricultural operations and livestock breeders. Laboratorios HIPRA serves customers in Spain. We are an Animal Health company and this is our sole activity.Through our own commercial subsidiaries and a global distribution network, we reach customers from more than 100 countries. HIPRA around the world Africa America Asia Europe Oceania

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Laboratorios HIPRASpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Avda. la Selva 135 17170 Amer (Girona)
    Telephone
    Telephone
    (+34) 972 43 06 60
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hipra.com/portal/en/hipra/home
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ACCORD and HIPRA Enter into Agreement to Commercialise COVID-19 vaccine BIMERVAX
    ACCORD and HIPRA Enter into Agreement to Commercialise COVID-19 vaccine BIMERVAX

    04 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/accord-and-hipra-enter-into-exclusive-distribution-agreement-to-commercialise-hipras-covid-19-vaccine-bimervax-in-the-united-kingdom-301892785.html

    PR NEWSWIRE
    04 Aug 2023
    Share Share
    EU signs joint procurement deal with Spain's HIPRA for COVID vaccines
    EU signs joint procurement deal with Spain's HIPRA for COVID vaccines

    03 Aug 2022

    // John Chalmers REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/eu-signs-joint-procurement-deal-with-hipra-covid-vaccines-2022-08-02/

    John Chalmers REUTERS
    03 Aug 2022
    Share Share
    EC’s HERA signs Covid-19 vaccine procurement deal with HIPRA
    EC’s HERA signs Covid-19 vaccine procurement deal with HIPRA

    03 Aug 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/hera-vaccine-deal-hipra/

    PHARMACEUTICAL-TECHNOLOGY
    03 Aug 2022
    Share Share
    EU starts real-time review of Hipra's COVID vaccine
    EU starts real-time review of Hipra's COVID vaccine

    30 Mar 2022

    // M. Roy REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/eu-starts-real-time-review-hipras-covid-vaccine-2022-03-29/

    M. Roy REUTERS
    30 Mar 2022
    Share Share
    Spanish regulator authorises phase III trials of Hipra's COVID vaccine
    Spanish regulator authorises phase III trials of Hipra's COVID vaccine

    02 Feb 2022

    // N. Allen REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/spanish-regulator-authorises-phase-iii-trials-hipras-covid-vaccine-2022-02-01/

    N. Allen REUTERS
    02 Feb 2022
    Share Share
    Spain's Hipra gets green light for Phase II COVID vaccine trials
    Spain's Hipra gets green light for Phase II COVID vaccine trials

    15 Nov 2021

    // REUTERS

    https://www.reuters.com/article/us-health-coronavirus-spain-vaccine/spains-hipra-gets-green-light-for-phase-ii-covid-vaccine-trials-idUSKBN2I0142

    REUTERS
    15 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search